Brazil Telemedicine Market Analysis Report 2022 to 2030

Brazil Telemedicine Market Analysis

$ 3999

Brazil's telemedicine market size was valued at $1.52 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 19.2% from 2022 to 2030 and will reach $6.19 Bn in 2030. The increasing prevalence of chronic diseases is driving demand for telemedicine services that can help manage these conditions. The market is segmented by component type, application type, modality type, and by delivery mode type. Some of the key players in the market are Amil, Minha Vida, Televida, São Francisco Saúde, Doctoralia, and others.

ID: IN10BRDH010 CATEGORY: Digital Health GEOGRAPHY: Brazil

Buy Now

Brazil Telemedicine Market Executive Summary

Brazil's telemedicine market size was valued at $1.52 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 19.2% from 2022 to 2030 and will reach $6.19 Bn in 2030. Brazil's gross domestic product (GDP) was around $2.055 trillion in 2020. The country's healthcare expenditure as a percentage of GDP was around 9.1% in the same year. Brazil has a mixed healthcare system, with both private and public sectors providing healthcare services. The public sector, which includes the national healthcare system (Sistema Único de Saúde, or SUS) and other government-funded programs, accounts for the majority of healthcare expenditure in the country. The SUS provides universal access to healthcare for all citizens and is funded through a combination of federal, state, and local taxes.

Telemedicine is strongly focused on teleradiology in Brazil, which represents over 98% of the market segment revenue. Other telemedicine applications encompass real-time solutions such as specialist consultation and distance learning/education. MHealth is a promising market with a broad range of applications including delivery through telemedicine. Nevertheless, it encounters several barriers to realizing the market potential. From wearables to apps, vital signs remote monitoring, and chronic disease management, mHealth is constantly transforming the entire ecosystem with new value propositions and solutions. Digital health in Brazil offers a huge opportunity given that industry convergence is transforming how care is delivered via the intersection between the healthcare and ICT industries.

Brazil is attracting numerous telemedicine projects due to governmental healthcare initiatives targeting low-income groups. In a country like Brazil, where there’s a huge social gap in the society, telemedicine is an effective option to reduce such gaps. This technology allows patients to save hours, reduce costs, minimize errors and get quality treatment even in the smallest of cities.

Brazil Telemedicine Market

Market Dynamics

Market Growth Drivers

Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases such as diabetes and cardiovascular diseases is driving demand for telemedicine services that can help manage these conditions. Furthermore, growing demand for convenient and accessible healthcare services: The growing demand for convenient and accessible healthcare services in Brazil is driving demand for telemedicine, which allows patients to receive medical care remotely without the need to physically visit a healthcare facility.

The expansion of broadband infrastructure in Brazil is making it easier for people to access telemedicine services, which is contributing to the growth of the market. Moreover, government initiatives: The Brazilian government has implemented several measures to support the growth of the telemedicine market, including the creation of a national telemedicine platform and the development of telemedicine guidelines and standards.

Market Restraints

The regulatory environment for telemedicine in Brazil is still evolving, and there are several regulatory barriers that may deter some companies from entering the market. Moreover, lack of standardization and interoperability: The lack of standardization and interoperability in the telemedicine market in Brazil may make it difficult for healthcare providers to integrate telemedicine services into their existing systems and processes. Furthermore, telemedicine services in Brazil are not currently reimbursed by the national healthcare system (Sistema Único de Saúde, or SUS), which may act as a deterrent for some healthcare providers considering offering these services.

Competitive Landscape

Key Players

Key players in the oncology market include

Amil (BRA)
Minha Vida (BRA)
Televida (BRA)
São Francisco Saúde (BRA)
Doctoralia (BRA)
Docway (BRA)
Medida Certa (BRA)
Saúde Digital (BRA)
Plena Saúde Plena Saúde Plena Saúde
Médicos Sem Fronteiras Plena Saúde
AMD Global Telemedicine Inc.
Philips Healthcare
Cloudvisit Telemedicine
Reach Health

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of Brazil Telemedicine Market

In Brazil, the regulation of telemedicine is the responsibility of the National Health Surveillance Agency (Agência Nacional de Vigilância Sanitária, or ANVISA). ANVISA is a federal agency that is responsible for regulating the quality, safety, and efficacy of healthcare products and services in Brazil, including telemedicine.

ANVISA has issued several resolutions and guidelines to regulate the use of telemedicine in Brazil. These include:

Resolution RDC No. 36/2013: This resolution outlines the general principles and requirements for the use of telemedicine in Brazil, including the requirement for healthcare providers to have a license to practice and the requirement for telemedicine services to be provided by qualified healthcare professionals
Resolution RDC No. 23/2017: This resolution establishes the technical and operational standards for the use of telemedicine in Brazil, including standards for the protection of patient privacy and the security of data transmission
Resolution RDC No. 107/2018: This resolution establishes the requirements for the use of remote patient monitoring systems in Brazil, including the requirement for the systems to be registered with ANVISA and the requirement for healthcare providers to have a license to use the systems

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Telemedicine Market Segmentation

Component

Product
- Hardware
- Software
- Others
Services
- Tele-consulting
- Tele-monitoring
- Tele-education

Modality

The industry is driven by three concepts, which include real-time (synchronous), store and forward (asynchronous), and others comprising remote patient monitoring, etc.

Store and forward
Real-time
Others

Application

Teleradiology
Telepsychiatry
Telepathology
Teledermatology
Telecardiology
Others

Delivery Mode

Web/Mobile
Audio/Text-based
Visualized
Call centers

Facility

Tele-hospital
Tele-home

End-user

Providers
Payers
Patients
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.